GLP-1 Makers Score Another Court Victory Against Compounders

By Jessica Karins / May 9, 2025 at 1:11 PM

In another victory for brand name GLP-1 drugmakers in their fight against compounded versions of their drugs, a district court judge in Texas upheld FDA’s decision to remove tirzepatide from the shortage list.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.